C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 491/20 (2006.01) A61K 31/438 (2006.01) A61K 31/4545 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 15/10 (2006.01) C07D 471/10 (2006.01)
Patent
CA 2624030
Certain novel N-acylated spiropiperidine derivatives are ligands of the human melanocortin receptor(s) and, in particular, are selective ligands of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of MC-4R, such as obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Certains nouveaux dérivés spiropipéridines acylés sont des ligands des récepteurs humains de la mélanocortine-4 (MC-4R). Ils conviennent donc pour le traitement de, la lutte contre, et la prévention d'affections et de troubles réagissant à la modulation de MC-4R, et notamment l'obésité, le diabète, la dépendance nicotinique, l'alcoolisme et les difficultés sexuelles y-compris les troubles de l'érection chez l'homme et les troubles de l'excitation sexuelle chez la femme.
Jian Tianying
Liu Jian
Nargund Ravi P.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Acylated spiropiperidine derivatives as melanocortin-4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated spiropiperidine derivatives as melanocortin-4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated spiropiperidine derivatives as melanocortin-4... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1724698